NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
24.69
-1.48%
After-hours: Aug 15, 2025, 06:42 PM EDT
NewAmsterdam Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -148.35M | -184.7M | -232.42M | -182.78M | -212.22M | -212.18M | -163.57M | -161.48M | -120.27M | -85.08M | -45.19M | -3.93M | 2.44M | 2.47M | 3.61M | 1.36M | -1.57M | -1.91M |
Depreciation & Amortization | 176K | 148.7K | 110.66K | 64.83K | 42.99K | 50.91K | 45.23K | 25.32K | 19.17K | -6.46K | -14.74K | 3.5K | 7K | 10.5K | 14K | 10.75K | 7.5K | 4.25K |
Stock-Based Compensation | 47.8M | 40.35M | 32.5M | 28.15M | 25.71M | 23.08M | 22.71M | 19.55M | 14M | 8.91M | 1.9M | 262.25K | 524.5K | 786.75K | 1.05M | 786.75K | 524.5K | 262.25K |
Other Working Capital | 1.44M | -683.57K | -10.09M | -2.87M | 1.63M | 2.15M | 472.82K | -4.82M | -5.34M | -2.01M | 930.04K | 3.82M | 1.91M | 120.3K | 194.23K | 158.29K | -27.66K | 29.59K |
Other Non-Cash Items | -26.15M | 26.75M | 49.31M | -1.35M | 5.13M | -27.46K | -26.55K | 6.57M | 6.53M | 10.91M | 9.35M | -143.9K | -4.49M | -2.88M | -3.91M | -3.5M | -1.61M | -2.37M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.4M | -11.19M | -30.97M | -20.56M | -17.97M | -1.81M | 7.09M | 63.25M | 62.72M | 61.89M | 62.38M | 3.83M | 1.92M | 124.56K | 198.49K | 26.29K | -291.66K | -366.4K |
Operating Cash Flow | -124.12M | -136.75M | -151.09M | -146.1M | -168.92M | -152.04M | -130.53M | -68.86M | -33.78M | -521.94K | 28.42M | -245.18K | -133.31K | -283.26K | -99.75K | -2.11M | -3.47M | -4.65M |
Capital Expenditures | -182K | -288.75K | -630.99K | -636.86K | -571.2K | -374.03K | -22.22K | -122.78K | -113.44K | -115.87K | -109.43K | -5K | -10K | -15K | -20K | -18.25K | -16.5K | -14.75K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -193.34M | -9.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 37.16M | 12.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -62.18M | -62.18M | -62.18M | -2.59M | -5.18M | -5.18M | -5.18M | -2.59M | n/a | n/a | n/a | 5K | 722K | 1.44M | 2.16M | 2.15M | 1.44M | 726.75K |
Investing Cash Flow | -218.53M | -59.59M | -62.81M | -3.23M | -5.75M | -398.7K | -46.89K | 2.44M | 5.04M | -115.87K | -109.43K | -5K | 707K | 1.42M | 2.13M | 2.13M | 1.42M | 702.25K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 11.59M | 12.82M | 14M | 13.13M | 13.27M | 14.94M | 9.44M | 162.12M | 161.93M | 155.59M | 153.35M | 5.44M | 5.44M | 22.68M | 39.97M | 37.33M | 40.18M | 25.77M |
Financial Cash Flow | 466.61M | 467.53M | 645.42M | 188.82M | 188.97M | 190.43M | 8.22M | 161.59M | 161.39M | 155.59M | 153.35M | 17.21M | 34.45M | 51.7M | 68.99M | 54.58M | 40.18M | 25.77M |
Net Cash Flow | 133.16M | 270.71M | 424.95M | 45.84M | 21.17M | 45.66M | -109.55M | -79.45M | -47.01M | -24.62M | -696.05K | -165.69K | -78.49K | -277.06K | -36.44K | 773.45K | 2.23M | 3.89M |
Free Cash Flow | -124.3M | -137.04M | -151.72M | -146.73M | -169.49M | -152.41M | -130.55M | -68.98M | -33.89M | -637.81K | 28.31M | -250.18K | -143.31K | -298.26K | -119.75K | -2.13M | -3.49M | -4.66M |